Skip to main content
CTVA
NYSE Life Sciences

Corteva, Vylor Unveil Standalone Guidance After Spin-Off; Shares Diverge

Tom Rudovsky · Reported by Benzinga
More coverage: Industrial
Sentiment info
Neutral
Importance info
7
Price
$11.955
Mkt Cap
$7.976B
52W Low
$11.84
52W High
$90.97
52W Position info
1.0% above low
Off High info
87% below high
Rel. Volume info
9.2× avg
Market data snapshot near publication time

CTVA is trading near its 52-week low of $11.84 (1.0% above the low) on elevated volume (9.2× avg).

Summary

Corteva completed its Vylor spin-off on Thursday, and Friday's trading shows a clear divergence: Vylor up 2.56% to $70.01, Corteva down 5.09% to $11.93. The article provides the first detailed standalone guidance for both companies. Corteva, now a pure-play crop protection firm, expects net sales to grow from $7.8B in 2026 to $8.4B-$8.7B by 2029, with EBITDA rising from $1.3B to $1.45B-$1.65B and margins exceeding 18%. Vylor, the seed and genetics business, targets 2029 net sales of $11.2B-$11.9B and EBITDA of $3.3B-$3.7B, backed by a $19B technology pipeline. This follows the spin-off's final legal clearance on October 1 and the first standalone financials filed the same day. The market's reaction suggests investors are reassessing Corteva's standalone value, with shares trading near their 52-week low.

At the time of this announcement, CTVA was trading at $11.96 on NYSE in the Life Sciences sector, with a market capitalization of approximately $8B. The 52-week trading range was $11.84 to $90.97. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

CTVA - Latest Insights

CTVA
Nov 16, 2026, 4:47 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $9.13
Real-time Price: $8.88 info
Change: -$0.2477 (-3%) info
Market Cap: $5.919B info
CTVA
Nov 12, 2026, 5:12 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $9.26
Real-time Price: $8.88 info
Change: -$0.380 (-4%) info
Market Cap: $5.919B info
CTVA
Nov 12, 2026, 11:47 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $9.82
Real-time Price: $8.88 info
Change: -$0.935 (-10%) info
Market Cap: $5.919B info
CTVA
Nov 12, 2026, 8:34 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.89
Real-time Price: $8.88 info
Change: -$2.01 (-18%) info
Market Cap: $5.919B info
CTVA
Nov 12, 2026, 5:45 AM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $10.89
Real-time Price: $8.88 info
Change: -$2.01 (-18%) info
Market Cap: $5.919B info